TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis

Thorax

Volumn 55, Issue 6, 2000, Pages 459-462

  Arkwright, Peter D ^a   Laurie, Steven ^a   Super, Maurice ^b   Pravica, Vera ^a   Schwarz, Martin J ^b   Webb, A Kevin ^c   Hutchinson, Ian V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Lung function tests; Polymorphisms; Transforming growth factor (TGF)

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHILD; CODON; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DETERMINATION; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RESPIRATORY INSUFFICIENCY; TRANSFORMING GROWTH FACTOR BETA; VITAL CAPACITY;

EID: 0034102868     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.6.459     Document Type: Article

References (17)

1. 1 Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-13.
2. 2 Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Ann Rev Genetics 1995;29:777-807.
3. 3 Roberts AB, Lamb LC, Newton DL, et al. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid ethanol extraction. Proc Natl Acad Sci USA 1980;77:3494-8.
4. 4 Ignotz R, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337.
5. 5 Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-β1 gene. Transplantation 1998;66:1014-20.
6. 6 Perrey C, Pravica V, Sinnott PJ, et al. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α: a technical report. Transplant Immunol 1998;6:193-7.
7. 7 Perrey C, Turner SJ, Pravica V, et al. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunol 1999;7:127-8.
8. 8 Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet 1999;8:93-7.
9. 9 Nakamura Y, Tate L, Ertl RF, et al. Bronchial epithelial cells regulate fibroblast proliferation. Am J Physiol 1995;269: L377-87.
10. 10 Franko AJ, Sharplin J, Ghahary A, et al. Immunochemical localization of transforming growth factor β and tumour necrosis factor α in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation. Radiat Res 1997;147:245-56.
11. 11 Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992;18:29-43.
12. 12 Corrin B, Butcher D, McAnulty BJ, et al. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 1994;24:145-50.
13. 13 El-Gamel A, Awad M, Sim E, et al. Transforming growth factor-beta-1 and lung allograft fibrosis. Eur J Cardiothorac Surg 1998;13:424-30.
14. 14 Bayer EM, Herr W, Kanzler S, et al. Transforming growth factor-beta-1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol 1998;28:803-11.
15. 15 Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999;96:2345-9.
16. 16 Kanzler S, Lohse AW, Keil A, et al. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrinogenesis. Am J Physiol 1999;276:G1059-68.
17. 17 Kopp JB, Factor VM, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 1996;74:991-1003.